RxDoctor Payments Data

John Cho, MD

Otolaryngology · Honolulu, HINPI 1184975096

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.7%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Smith+Nephew at 32.1% of the total. Reporting peaked in 2023 at $3,733 and has fallen 81.2% since, to $700 in 2025. Among otolaryngology clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,099in general payments, 2019–2025

Across 118 payments — averaging $85.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$3K
  • Intersect ENT, Inc.$2K
  • Acclarent, Inc$2K
  • Medical Device Business Services, Inc.$2K
  • Integra Lifesciences Corporation$885
  • Medtronic$455
  • plus $199 from 3 others

What the payments were for

  • Travel & lodging$4,37043%
  • Food & beverage$5,72557%
  • Gifts$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,099 in reported general payments places this provider in the 95th percentile of 33 otolaryngology providers in Hawaii.

See all otolaryngology providers in Hawaii

Medicare billing

Part B allowed, 2024
$211,255
Medicare patients
298
Services billed
1,503

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Budesonide81$13,793
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth57$7,776
Ofloxacin51$2,698
Gentamicin Sulfate45$2,612
Fluticasone Propionate111$1,592
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav58$1,286
Ipratropium Bromide19$679
Omeprazole30$631
Azithromycin51$402
Ciprofloxacin Hcl28$313
Mupirocin26$175
Methylprednisolone11$90
Cephalexin11$72
Oxycodone Hcl25$66
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen22$52

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Honolulu

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →